Head-to-head · Value Score
bmiMD vs Kina
Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, Kina a 75. Here's who gives you the honest lower price — and where each one bites back.
bmiMD
#11 · Grade A · Great Deal
Est. first month
$99/mo
Save ~93% vs brand-nameKina
#129 · Grade C+ · Fair Price
Est. first month
From $179/mo (starting dose, plus a separate fee, compounded)
Save ~87% vs brand-nameThe verdict
bmiMD takes it on Value Score, 89 to 75 — an est. $99/mo first month, with no teaser step-up baked in. Kina isn't out of it: Shoppers who want women in menopause wanting GLP-1 weight care alongside HRT, from board-certified physicians.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | bmiMD | Kina |
|---|---|---|
| Value Score | 89 (A) | 75 (C+) |
| Est. first month | $99/mo | From $179/mo (starting dose, plus a separate fee, compounded) |
| Save vs brand-name | ~93% | ~87% |
| Semaglutide | $99/mo | From $179/mo (starting dose, plus a separate fee, compounded) |
| Tirzepatide | $139/mo | From $179/mo (starting dose, compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
bmiMD
Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.
Why it's a deal
- $99 flat semaglutide and a low $139 tirzepatide
- Available in all 50 states
- Both molecules priced up front
The fine print
- Not LegitScript-certified — do your own pharmacy diligence
- Thin public track record; no oral or brand-name option
Kina
Kina is a menopause-care telehealth platform where GLP-1 is the weight-loss treatment, offered alongside HRT, peptide, and compounded options for menopause symptoms.
Why it's a deal
- Menopause-specialized care — GLP-1 weight treatment alongside HRT, peptide, and compounded options for menopause symptoms
- Prescribed and monitored by named board-certified physicians at Arora Health & Aesthetics, with dose adjustments included
- Verifiable LegitScript certification (seal ID 50917967)
- GLP-1 from $179/month with $0 membership fees, FSA/HSA eligibility, free shipping, and cancel-anytime
- Compounded semaglutide and tirzepatide, 100% online with a roughly 2-minute intake
The fine print
- Compounded medications are not FDA-approved — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
- Built for women navigating menopause — less tailored if that is not your situation
- A separate $50 physician consultation fee applies on top of the medication price
- The compounding pharmacy partner is not named, and the full list of served states is not published
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores bmiMD is ranked on the bmiMD alternatives board, and the same list for the other side is on alternatives to Kina.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.